LPJ Issued Patent
SEYMOUR, Ill.--LPJ Research Inc. announced it has been issued a patent for its prohormone 19-Nor-4-Androstenediol. The patent, number 6,011,027, was granted on the basis that 19-Nor-4-Androstenediol increases 19-nortestosterone levels in humans. 19-Nor-4-Androstenediol is a close chemical derivative of testosterone, which is known for its ability to increase lean muscle and bone mass, improve sexual function and promote psychological well being, according to LPJ. For more information, contact LPJ at (217) 687-4138.